Log in
RegisterIt's all about the money [BE/BA News]
I can't understand how sponsors risk their business for 40 ou 50k€
I know that generics is a business of spend the less amount possible to win the most. But the difference in price of a bioequivalence study in China/India or Europe sometimes does not worth the risk of these things happen and ruin the entire image of the generics industry. At least in Portugal, even the medical comunity don't trust generics and generic companies. And this news just make things worst.
I know that generics is a business of spend the less amount possible to win the most. But the difference in price of a bioequivalence study in China/India or Europe sometimes does not worth the risk of these things happen and ruin the entire image of the generics industry. At least in Portugal, even the medical comunity don't trust generics and generic companies. And this news just make things worst.
Complete thread:
- 1,000+ Chinese NDAs rejected due to fabricated or incomplete clinical data Helmut 2016-09-28 20:55 [BE/BA News]
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- It's all about the moneyDavidManteigas 2016-09-29 10:37
- It's all about the money ElMaestro 2016-09-30 22:58
- It's all about the moneyDavidManteigas 2016-09-29 10:37
Ing. Helmut Schütz